652 related articles for article (PubMed ID: 27352852)
1. Coevolution of URAT1 and Uricase during Primate Evolution: Implications for Serum Urate Homeostasis and Gout.
Tan PK; Farrar JE; Gaucher EA; Miner JN
Mol Biol Evol; 2016 Sep; 33(9):2193-200. PubMed ID: 27352852
[TBL] [Abstract][Full Text] [Related]
2. Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.
Jutabha P; Anzai N; Kitamura K; Taniguchi A; Kaneko S; Yan K; Yamada H; Shimada H; Kimura T; Katada T; Fukutomi T; Tomita K; Urano W; Yamanaka H; Seki G; Fujita T; Moriyama Y; Yamada A; Uchida S; Wempe MF; Endou H; Sakurai H
J Biol Chem; 2010 Nov; 285(45):35123-32. PubMed ID: 20810651
[TBL] [Abstract][Full Text] [Related]
3. Discovery and characterization of verinurad, a potent and specific inhibitor of URAT1 for the treatment of hyperuricemia and gout.
Tan PK; Liu S; Gunic E; Miner JN
Sci Rep; 2017 Apr; 7(1):665. PubMed ID: 28386072
[TBL] [Abstract][Full Text] [Related]
4. The effects of URAT1/SLC22A12 nonfunctional variants, R90H and W258X, on serum uric acid levels and gout/hyperuricemia progression.
Sakiyama M; Matsuo H; Shimizu S; Nakashima H; Nakamura T; Nakayama A; Higashino T; Naito M; Suma S; Hishida A; Satoh T; Sakurai Y; Takada T; Ichida K; Ooyama H; Shimizu T; Shinomiya N
Sci Rep; 2016 Jan; 6():20148. PubMed ID: 26821810
[TBL] [Abstract][Full Text] [Related]
5. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
6. URAT1 inhibition by ALPK1 is associated with uric acid homeostasis.
Kuo TM; Huang CM; Tu HP; Min-Shan Ko A; Wang SJ; Lee CP; Ko YC
Rheumatology (Oxford); 2017 Apr; 56(4):654-659. PubMed ID: 28039413
[TBL] [Abstract][Full Text] [Related]
7. Stronger Uricosuric Effects of the Novel Selective URAT1 Inhibitor UR-1102 Lowered Plasma Urate in Tufted Capuchin Monkeys to a Greater Extent than Benzbromarone.
Ahn SO; Ohtomo S; Kiyokawa J; Nakagawa T; Yamane M; Lee KJ; Kim KH; Kim BH; Tanaka J; Kawabe Y; Horiba N
J Pharmacol Exp Ther; 2016 Apr; 357(1):157-66. PubMed ID: 26907620
[TBL] [Abstract][Full Text] [Related]
8. Renal urate handling: clinical relevance of recent advances.
Anzai N; Enomoto A; Endou H
Curr Rheumatol Rep; 2005 Jun; 7(3):227-34. PubMed ID: 15919000
[TBL] [Abstract][Full Text] [Related]
9. Urate Transporter URAT1 in Hyperuricemia: New Insights from Hyperuricemic Models.
Li X; Yan Z; Tian J; Zhang X; Han H; Ye F
Ann Clin Lab Sci; 2019 Nov; 49(6):756-762. PubMed ID: 31882426
[TBL] [Abstract][Full Text] [Related]
10. Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.
Vázquez-Mellado J; Alvarado-Romano V; Burgos-Vargas R; Jiménez-Vaca AL; Pozo-Molina G; Cuevas-Covarrubias SA
J Clin Pathol; 2007 Aug; 60(8):947-8. PubMed ID: 17660342
[No Abstract] [Full Text] [Related]
11. Contribution of Rare Variants of the
Misawa K; Hasegawa T; Mishima E; Jutabha P; Ouchi M; Kojima K; Kawai Y; Matsuo M; Anzai N; Nagasaki M
Genetics; 2020 Apr; 214(4):1079-1090. PubMed ID: 32005656
[TBL] [Abstract][Full Text] [Related]
12. [Historical review of gout and hyperuricemia investigations].
Nakamura T
Nihon Rinsho; 2008 Apr; 66(4):624-35. PubMed ID: 18409506
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in renal urate transport: characterization of candidate transporters indicated by genome-wide association studies.
Anzai N; Jutabha P; Amonpatumrat-Takahashi S; Sakurai H
Clin Exp Nephrol; 2012 Feb; 16(1):89-95. PubMed ID: 22038265
[TBL] [Abstract][Full Text] [Related]
14. [Physiology and biochemistry of uric acid].
Hediger MA
Ther Umsch; 2004 Sep; 61(9):541-5. PubMed ID: 15493112
[TBL] [Abstract][Full Text] [Related]
15. Modified Chuanhu anti-gout mixture, a traditional Chinese medicine, protects against potassium oxonate-induced hyperuricemia and renal dysfunction in mice.
You W; Wang J; Zou Y; Che K; Hou X; Fei H; Wang Y
J Int Med Res; 2019 May; 47(5):1927-1935. PubMed ID: 30832523
[TBL] [Abstract][Full Text] [Related]
16. DKB114, A Mixture of
Lee YS; Kim SH; Yuk HJ; Kim DS
Nutrients; 2018 Sep; 10(10):. PubMed ID: 30274153
[No Abstract] [Full Text] [Related]
17. Substantial anti-gout effect conferred by common and rare dysfunctional variants of URAT1/SLC22A12.
Toyoda Y; Kawamura Y; Nakayama A; Nakaoka H; Higashino T; Shimizu S; Ooyama H; Morimoto K; Uchida N; Shigesawa R; Takeuchi K; Inoue I; Ichida K; Suzuki H; Shinomiya N; Takada T; Matsuo H
Rheumatology (Oxford); 2021 Nov; 60(11):5224-5232. PubMed ID: 33821957
[TBL] [Abstract][Full Text] [Related]
18. Association between intronic SNP in urate-anion exchanger gene, SLC22A12, and serum uric acid levels in Japanese.
Shima Y; Teruya K; Ohta H
Life Sci; 2006 Nov; 79(23):2234-7. PubMed ID: 16920156
[TBL] [Abstract][Full Text] [Related]
19. [Molecular mechanisms of urate transport in renal tubules: localization and function of urate transporters].
Kanai Y
Nihon Rinsho; 2008 Apr; 66(4):659-66. PubMed ID: 18409511
[TBL] [Abstract][Full Text] [Related]
20. Baicalein alleviates hyperuricemia by promoting uric acid excretion and inhibiting xanthine oxidase.
Chen Y; Zhao Z; Li Y; Yang Y; Li L; Jiang Y; Lin C; Cao Y; Zhou P; Tian Y; Wu T; Pang J
Phytomedicine; 2021 Jan; 80():153374. PubMed ID: 33075645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
